Quantification of Neurocognitive Changes Before, During, and After Hyperbaric Oxygen Therapy in a Case of Fetal Alcohol Syndrome
Posted on: Wednesday, 19 October 2005, 03:00 CDT
By Stoller, Kenneth P
e586 ABSTRACT. Quantification of Neurocognitive Changes Before, During, and After Hyperbaric Oxygen Therapy in a Case of Fetal Alcohol Syndrome. Kenneth P. Stoller, MD. Fetal alcohol syndrome (FAS) is the most common nonhereditary cause of mental retardation, with deficits in general intellectual functioning, learning, memory, attention, and problem-solving. Presented here is the first case in which measured neurocognitive abilities were determined before, during, and after hyperbaric oxygen therapy in a case of FAS involving a teenage male patient. Memory, reaction time, and visual motor speed assessments were compared. After 40 hyperbaric treatments with 100% oxygen at 1.5 atmospheres absolute, the patient's performance in 6 of 6 categories of the computer- administered test battery improved. Word composite (verbal) scores improved from 55% to 73%, memory composite (visual) scores improved from 38% to 55%, reaction time composites improved from 1.03 to 0.53 seconds, impulse control composite scores improved from 8 to 5, and visual motor speed scores improved from 18.6 to 19.03. The patient's subjective symptoms diminished 94%. Six months after these treatments, the patient's verbal memory was maintained at 73% without any other interventions; impulsivity continued to improve, whereas other indices did not. Thirty-three additional treatments continued to improve test performance, with verbal memory at 95%, visual memory at 57%, and a 100% reduction of subjective symptoms. This patient, with 15-year-matured FAS, benefited from a short course of low-pressure hyperbaric oxygen therapy, sustained durable cognitive improvements, and continued to exhibit improvement with another short course of treatments.
Copyright American Academy of Pediatrics Oct 2005
Source: Pediatrics
Related Articles
- ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five-Fold Over Typical Primary Care
- Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
- Michigan Hospitals Support Comprehensive Initiative to Prevent Medical Errors and Improve Patient Safety
- AstraZeneca's Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer By 2016
- Emory Healthcare Uses SciHealth to Improve Patient Satisfaction
- Cottage Hospital Improves Patient Care, Cuts Costs With Radiology Upgrade
- Pharmatech, Inc. Selects OmniComm Systems, Inc. As Its Preferred Electronic Data Capture (EDC) Vendor and Enters Into a Strategic Partnership to Co-Develop Next Generation Solutions for Improving Patient Accrual
- Bethesda Memorial Hospital Selects Eclipsys Sunrise Critical Care(TM) to Help Improve Patient-Care Outcomes in High-Acuity Care Setting
- UK Health Secretary Unveils Plans to Improve Patient Choice
- New Planning Tool Streamlines Brachytherapy Treatments and Improves Patient Comfort
 |
 |
User Comments (0)
RSS Feeds